British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 6 , Pages 470-475 , September 2009

Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma

  • Hai-Gang Li

      Affiliations

    • Department of Pathology, the Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
    • ,
  • Jin-Song Li

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, 107 Yanjiang West Rd, Guangzhou 510120, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 20 81332429; fax: +86 20 81332853.
    • ,
  • Wei-Liang Chen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, 107 Yanjiang West Rd, Guangzhou 510120, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 20 81332429; fax: +86 20 81332853.
    • ,
  • Lin Wang

      Affiliations

    • Department of Pathology, the Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
    • ,
  • Dong-Hui Wu

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, 107 Yanjiang West Rd, Guangzhou 510120, China
    • ,
  • Zhao-Yu Lin

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, 107 Yanjiang West Rd, Guangzhou 510120, China

,Accepted 1 June 2009.

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43–66
  2. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C, Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope. 2002;112:616–625
  3. Lacombe C, Mateux P. Biology of erythropoietin. Haematologica. 1998;83:724–732
  4. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur J Clin Invest. 2003;33:891–896
  5. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res. 2002;51:472–478
  6. Sekiguchi N, Inoguchi T, Kobayashi K, Nawata H. Effect of erythropoietin on endothelial cell apoptosis induced by high glucose. Diabetes Res Clin Pract. 2004;66(Suppl. 1):103–107
  7. Lai SY, Childs EE, Xi S, et al. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene. 2005;24:4442–4449[Erratum in Oncogene 2005; 24:8126]
  8. Mohyeldin A, Lu H, Dalgard C, et al. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia. 2005;7:537–543
  9. Horak ER, Leek R, Klenk N, et al. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992;340:1120–1124
  10. Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia–glycolysis–acidosis sequence. Gynecol Oncol. 2008;108:377–384
  11. Batra S, Perelman N, Luck LR, Shimada H, Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest. 2003;83:1477–1487
  12. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer. 2002;95:969–981
  13. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 2000;58:647–657
  14. Acs G, Zhang PJ, McGrath CM, et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol. 2003;162:1789–1806
  15. Nakamatsu K, Nishimura Y, Suzuki M, Kanamori S, Maenishi G, Yasuda Y. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced hepatic tumors. Int J Clin Oncol. 2004;9:184–188
  16. Roh JL, Cho KJ, Kwon GY, et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol. 2009;45:63–68

PII: S0266-4356(09)00215-0

doi: 10.1016/j.bjoms.2009.06.001

British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 6 , Pages 470-475 , September 2009

Article Tools

* Image Usage & Resolution